Tamoxifen Citrate m...

Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1
Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1
Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1
Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1
Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1

Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1

Min.Order / FOB Price:Get Latest Price

0 Metric Ton

Negotiable

  • Min.Order :0 Metric Ton
  • Purity: >99%

Keywords

Tamoxifen Citrate manufacturer 54965-24-1 in stock low price 54965-24-1

Quick Details

  • Appearance:White solid
  • Application:pharmaceutical intermediates
  • PackAge:1kg/Aluminum foil package, 25Kg/Drum
  • ProductionCapacity:|Metric Ton|Day
  • Storage:Normal temperature
  • Transportation:FEDEX,DHL,EMS,Special line guarantee delivery

Superiority:

Tamoxifen Citrate manufacturer in stock low price 54965-24-1 

Tamoxifen Citrate is a potent and selective inhibitor of PKC (protein kinase C). It is known that Tamoxifen Citrate functions in PKC ε translocation. Studies suggest that Tamoxifen Citrate functions as an estrogen receptor antagonist in breast tissue. Once bound to the estrogen receptor Tamoxifen Citrate will not allow any other ligand to bind to the receptor. In contrast, Tamoxifen Citrate is an agonist towards this receptor in tissues of the endometrium. Studies indicate Tamoxifen Citrate inhibits DNA synthesis and transcription by recruiting co-repressors, which stop estrogen from interacting with genes. When combined with PAX2, Tamoxifen Citrate can inhibit the proliferation of ERBB2. It is also a high affinity activator of the GPR30 receptor. Tamoxifen Citrate is an activator of Estrogen Receptor.

Tamoxifen citrate is a widely used nonsteroidal anti-estrogen agent for the treatment of hormone-dependent breast cancer. Tamoxifen is a prodrug and extensively metabolized by cytochrome P450 (CYP450) enzymes into active metabolites including 4-hydroxytamoxifen and endoxifen (4-hydroxy-N-desmethyltamoxifen). They act as an estrogen receptor antagonist in breast tissue. Tamoxifen is commonly referred to as a selective estrogen receptor modulator (SERM), since it behaves as an estrogen receptor agonist in other tissues.

Details:

Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo. Also high affinity agonist at the membrane estrogen receptor GPER. Tamoxifen (Cat.No. 6432) is also available.

  • Product name

    Tamoxifen citrate, Estrogen receptor antagonist and partial agonist

  • Description

    Estrogen receptor antagonist and partial agonist

  • Biological description

    Competitive estrogen receptor antagonist and partial agonist. Inhibits estrogen dependent gene transcription and tumor growth. Additionally decreases cardiac infarction and inhibits Kir2.1, Kir2.2 and Kir2.3 potassium channels (IC50 values are 0.93, 0.87 and 0.31 µM, respectively).

  • Purity

    > 99%

  • CAS Number

    54965-24-1

  • Chemical structure

    Chemical Structure

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View